UBS/PUT/PFIZER INC/27/0.1/20.09.24 | Delayed Deutsche Boerse AG 08:34:27 2024-07-12 am EDT | ||
| 0.056 EUR | -9.68% |
|
| 1 month | -34.04% | ||
| 3 months | -70.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.056 | -9.68% |
| 24-07-11 | 0.062 | +34.78% |
| 24-07-10 | 0.046 | -33.33% |
| 24-07-09 | 0.069 | +18.97% |
| 24-07-08 | 0.058 | +7.41% |
Delayed Quote Deutsche Boerse AG
Last update July 12, 2024 at 08:34 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | UBS |
| WKN | UL9NF1 |
| ISIN | CH1302940247 |
| Date issued | 2023-11-02 |
| Strike | 27 $ |
| Maturity | 2024-09-20 (70 Days) |
| Parity | 10 : 1 |
| Emission price | 0.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.28 € |
|---|---|
| Lowest since issue | 0.029 € |
| Spread | 0.008 € |
| Spread % | 12.70% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66
USD
Average target price
32.01
USD
Spread / Average Target
+11.68%
- Stock Market
- Warrants
- Warrant
